Cardiovascular disease in patients with chronic kidney disease

References

• SarnakMJLeveyASEpidemiology of cardiac disease in dialysis patientsSeminars in Nephrology1999126976
   Google Scholar
• TesarVCardiovascular complications in patients with chronic renal insufficiency and chronic kidney failureVnitr Lek2003495 38338712908173
   PubMedGoogle Scholar
• LindholmBWangTHeimburgerOBergstromJInfluence of different treatments and schedules on the factors conditioning the nutritional status in dialysis patientsNephrol Dial Transplant199813 Suppl 666739719208
   PubMed Web of Science ®Google Scholar
• deLSChanTStevensPO’DonoghueDHagueNDzregahBIdentifying patients with chronic kidney disease from general practice computer recordsFam Pract200522323424115814579
   PubMed Web of Science ®Google Scholar
• ParikhNIHwangSJLarsonMGLevyDFoxCSChronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study)Am J Cardiol20081021475318572034
   PubMed Web of Science ®Google Scholar
• LevinASingerJThompsonCRRossHLewisMPrevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for interventionAm J Kidney Dis19962733473548604703
   PubMed Web of Science ®Google Scholar
• KeithDSNicholsGAGullionCMBrownJBSmithDHLongitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organizationArch Intern Med2004164665966315037495
   PubMed Web of Science ®Google Scholar
• McClellanWMChertowGMBeyond Framingham: cardiovascular risk profiling in ESRDJ Am Soc Nephrol20051661539154115872082
   PubMed Web of Science ®Google Scholar
• BergstromJLindholmBMalnutrition, cardiac disease, and mortality: an integrated point of viewAm J Kidney Dis19983258348419820457
   PubMed Web of Science ®Google Scholar
• deMRSnijderMBvan der Sman-de BeerSeidellJCBoeschotenEWKredietRTAssociation between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-upJ Am Soc Nephrol200718396797417267739
   PubMed Web of Science ®Google Scholar
• GoldwasserPMittmanNAntignaniABurrellDMichelMACollierJPredictors of mortality in hemodialysis patientsJ Am Soc Nephrol199339161316228507818
   PubMed Web of Science ®Google Scholar
• JafarTHStarkPCSchmidCHLandaMMaschioGDe JongPEProgression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysisAnn Intern Med2003139424425212965979
   PubMed Web of Science ®Google Scholar
• FellstromBHoldaasHJardineAGHolmeINybergGFauchaldPEffect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trialKidney Int20046641549155515458450
   PubMed Web of Science ®Google Scholar
• FellstromBJardineAGSoveriIColeENeumayerHHMaesBRenal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantationAm J Transplant2005581986199115996249
   PubMed Web of Science ®Google Scholar
• WannerCKraneVMarzWOlschewskiMMannJFRufGAtorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysisN Engl J Med2005353323824816034009
   PubMed Web of Science ®Google Scholar
• SilberbergJRacineNBarrePSnidermanADRegression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietinCan J Cardiol199061142138048
   PubMed Web of Science ®Google Scholar
• BesarabABoltonWKBrowneJKEgrieJCNissensonAROkamotoDMThe effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetinN Engl J Med199833995845909718377
   PubMed Web of Science ®Google Scholar
• KellerCKBergisKHFliserDRitzERenal findings in patients with short-term type 2 diabetesJ Am Soc Nephrol1996712262726358989741
   PubMed Web of Science ®Google Scholar
• RuggenentiPFassiAIlievaAPBrunoSIlievIPBruseganVPreventing microalbuminuria in type 2 diabetesN Engl J Med2004351191941195115516697
   PubMed Web of Science ®Google Scholar
• PatelAMacMahonSChalmersJNealBWoodwardMBillotLEffects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trialLancet2007370959082984017765963
   PubMed Web of Science ®Google Scholar
• MakinoHHanedaMBabazonoTMoriyaTItoSIwamotoYPrevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetesDiabetes Care20073061577157817389334
   PubMed Web of Science ®Google Scholar
• ParvingHHLehnertHBrochner-MortensenJGomisRAndersenSArnerPThe effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetesN Engl J Med20013451287087811565519
   PubMed Web of Science ®Google Scholar
• BrennerBMCooperMEdeZDKeaneWFMitchWEParvingHHEffects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyN Engl J Med200134512 86186911565518
   PubMed Web of Science ®Google Scholar
• LewisEJHunsickerLGClarkeWRBerlTPohlMALewisJBRenoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesN Engl J Med20013451285186011565517
   PubMed Web of Science ®Google Scholar
• BerlTHunsickerLGLewisJBPfefferMAPorushJGRouleauJLImpact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy TrialJ Am Soc Nephrol20051672170217915930097
   PubMed Web of Science ®Google Scholar
• GaedePHJepsenPVLarsenJNJensenGVParvingHHPedersenOBThe Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetesUgeskr Laeger2003165262658266112886549
   PubMedGoogle Scholar
• FliserDFranekEJoestMBlockSMutschlerERitzERenal function in the elderly: impact of hypertension and cardiac functionKidney Int1997514119612049083286
   PubMed Web of Science ®Google Scholar
• FarmerCKGoldsmithDJCoxJDallynPKingswoodJCSharpstonePAn investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variabilityNephrol Dial Transplant19971211230123079394315
   PubMed Web of Science ®Google Scholar
• The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathyLancet19973499069185718639217756
   PubMed Web of Science ®Google Scholar
• ShulmanNBFordCEHallWDBlaufoxMDSimonDLangfordHGPrognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative GroupHypertension1989135 SupplI80I932490833
   PubMedGoogle Scholar
• RostandSGBrownGKirkKARutskyEADustanHPRenal insufficiency in treated essential hypertensionN Engl J Med1989320116846882922014
   PubMed Web of Science ®Google Scholar
• HannedoucheTAlbouzeGChauveauPLacourBJungersPEffects of blood pressure and antihypertensive treatment on progression of advanced chronic renal failureAm J Kidney Dis1993215 Suppl 2 1311378494012
   PubMed Web of Science ®Google Scholar
• Renal AssociationTreatments of adults and children with renal failure: standards and audit measuresLondonRoyal College of Physicians of London and the Renal Association2002
   Google Scholar
• HanssonLZanchettiACarruthersSGDahlofBElmfeldtDJuliusSEffects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study GroupLancet19983519118175517629635947
   PubMed Web of Science ®Google Scholar
• LondonGMGuerinAPMarchaisSJMetivierFPannierBAddaHArterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortalityNephrol Dial Transplant20031891731174012937218
   PubMed Web of Science ®Google Scholar
• LehtoSNiskanenLSuhonenMRonnemaaTLaaksoMMedial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitusArterioscler Thromb Vasc Biol19961689789838696962
   PubMed Web of Science ®Google Scholar
• IbelsLSAlfreyACHufferWECraswellPWAndersonJTWeilRIIIArterial calcification and pathology in uremic patients undergoing dialysisAm J Med1979665790796443254
   PubMed Web of Science ®Google Scholar
• MatsuokaMIsekiKTamashiroMFujimotoNHigaNToumaTImpact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysisClin Exp Nephrol200481545815067517
   PubMedGoogle Scholar
• YildizAMemisogluEOflazHYaziciHPusurogluHAkkayaVAtherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patientsNephrol Dial Transplant200520476076715716296
   PubMed Web of Science ®Google Scholar
• WangAYWangMWooJLamCWLiPKLuiSFCardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective studyJ Am Soc Nephrol200314115916812506148
   PubMed Web of Science ®Google Scholar
• GiachelliCMBaeNDenhardtDTAlpersCESchwartzSMOsteopontin is elevated during neointima formation in rat arteries and is a novel component of artherosclerotic plaquesJ Clin Invest199392168616968408622
   PubMed Web of Science ®Google Scholar
• YangHCuringaGGiachelliCMElevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitroKidney Int20046662293229915569318
   PubMed Web of Science ®Google Scholar
• BraunJOldendorfMMoshageWElectron beam computer tomography in the evaluation of cardiac calcification in chronic dialysis patientsAm J Kidney Dis1996273944018604709
   PubMed Web of Science ®Google Scholar
• HutchisonAJWhitehouseRWBoultonHFAdamsJEMawerEBFreemontTJCorrelation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal diseaseKidney Int1993445107110778264137
   PubMed Web of Science ®Google Scholar
• BlockGASpiegelDMEhrlichJMehtaRLindberghJDreisbachAEffects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysisKidney Int20056841815182416164659
   PubMed Web of Science ®Google Scholar
• SukiWNZabanehRCangianoJLReedJFischerDGarrettLEffects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patientsKidney Int20077291130113717728707
   PubMed Web of Science ®Google Scholar
• MoeSMReslerovaMKettelerMO’NeillKDuanDKoczmanJRole of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD)Kidney Int2005676 2295230415882271
   PubMed Web of Science ®Google Scholar
• LevinAClinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysisSemin Dial200316210110512641872
   PubMed Web of Science ®Google Scholar
• LondonGMParfreyPSCardiac disease in chronic uremia: pathogenesisAdv Ren Replace Ther1997431942119239425
   PubMedGoogle Scholar
• FoleyRNParfreyPSHarnettJDKentGMMartinCJMurrayDCClinical and echocardiographic disease in patients starting end-stage renal disease therapyKidney Int19954711861927731145
   PubMed Web of Science ®Google Scholar
• MarkPBJohnstonNGroenningBAFosterJEBlythKGMartinTNRedefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imagingKidney Int200669101839184516508657
   PubMed Web of Science ®Google Scholar
• PascualJTeruelJLMoyaJLLianoFJimenez-MenaMOrtunoJRegression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective studyClin Nephrol19913562802871831414
   PubMed Web of Science ®Google Scholar
• WillenheimerRDahlofBRydbergEErhardtLAT1-receptor blockers in hypertension and heart failure: clinical experience and future directionsEur Heart J19992014997100810381851
   PubMed Web of Science ®Google Scholar
• IwaiNOhmichiNNakamuraYKinoshitaMDD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophyCirculation1994906262226287994801
   PubMed Web of Science ®Google Scholar
• StaessenJAWangJGGinocchioGPetrovVSaavedraAPSoubrierFThe deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal riskJ Hypertens19971512 Pt 2157915929488209
   PubMed Web of Science ®Google Scholar
• MclaughlinKJHardenPNUedaSBoulton-JonesJMConnellJMJardineAGThe role of genetic polymorphisms of angiotensin-converting enzyme in the progression of renal diseasesHypertension19962859129158901844
   PubMed Web of Science ®Google Scholar
• LositoAKalidasKSantoniSCeccarelliLJefferySPolymorphism of renin-angiotensin system genes in dialysis patients – association with cerebrovascular diseaseNephrol Dial Transplant200217122184218812454231
   PubMed Web of Science ®Google Scholar
• SummersAMCoupesBMBrennanMFRalphSAShortCDBrenchleyPEVEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5Nephrol Dial Transplant200520112427243216046504
   PubMed Web of Science ®Google Scholar
• LingWZhaohuiNBenHLeyiGJianpingLHuiliDUrinary IL-18 and NGAL as Early Predictive Biomarkers in Contrast-Induced Nephropathy after Coronary AngiographyNephron Clin Pract20081083c176c18118287807
   PubMedGoogle Scholar
• PfefferMASwedbergKGrangerCBHeldPMcMurrayJJMichelsonELEffects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programmeLancet2003362938675976613678868
   PubMed Web of Science ®Google Scholar
• CohnJNTognoniGA randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failureN Engl J Med2001345231667167511759645
   PubMed Web of Science ®Google Scholar
• PresneCMansourJMakdassiRChoukrounGFournierAThe COOPERATE trialLancet20033619362105412660076
   PubMedGoogle Scholar
• MogensenCENeldamSTikkanenIOrenSViskoperRWattsRWRandomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) studyBMJ200032172741440144411110735
   PubMed Web of Science ®Google Scholar
• MannJFSchmiederREMcQueenMDyalLSchumacherHPogueJRenal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trialLancet2008372963854755318707986
   PubMed Web of Science ®Google Scholar
• KaragiannisSEFeringaHHElhendyAvanDRChoncholMVidakovicRPrognostic significance of renal function in patients undergoing dobutamine stress echocardiographyNephrol Dial Transplant200823260160718003663
   PubMed Web of Science ®Google Scholar
• BergeronSHillisGSHaugenENOhJKBaileyKRPellikkaPAPrognostic value of dobutamine stress echocardiography in patients with chronic kidney diseaseAm Heart J2007153338539117307417
   PubMed Web of Science ®Google Scholar